FDA updates labeling for REZZAYO FDA Approval Dec. 11, 2025, 09:44 UTC Labeling changes approved for MUNDIPHARMA. Active ingredient: REZAFUNGIN ACETATE. Decision date: 12/10/2025 Full text
There are no comments here yet...